Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Brawn Biotech Debt & Borrowing

Brawn Biotech Limited confirmed it does not meet the SEBI criteria to be classified as a Large Corporate as of March 31, 2025. The company reported zero outstanding borrowings under the framework. This annual regulatory disclosure ensures compliance with SEBI debt-raising norms for the 2026 financial year.

Source

BSE filing, NSE: BRAWN. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Brawn Biotech Ltd: key numbers

Share price
₹24.61
Market cap
₹7.38 Cr
Revenue (annual)
₹16.98 Cr
Net profit (annual)
₹0.94 Cr
P/E (TTM)
8.6×Sector 45.9×
Promoter holding
52.94%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Brawn Biotech Ltd

All →

Other debt & borrowing announcements

All →